Skip to main content

Hyponatremia, euvolemic News

FDA Medwatch Alert: Samsca (Tolvaptan): Drug Safety Communication - FDA Limits Duration and Usage Due To Possible Liver Injury Leading to Organ Transplant or Death

ISSUE: FDA has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver...

Ask a question

To post your own question to our community, sign in or create an account.